Further Implications of Off-Label Use of Acetazolamide in the Management of Moyamoya Disease in Japan: Response

Radiology. 2017 Jul;284(1):301-303. doi: 10.1148/radiol.2017170252.
No abstract available

Publication types

  • Letter
  • Comment